Cargando…

Indoline-5-Sulfonamides: A Role of the Core in Inhibition of Cancer-Related Carbonic Anhydrases, Antiproliferative Activity and Circumventing of Multidrug Resistance

The overexpression and activity of carbonic anhydrase (CA, EC 4.2.1.1) isoforms CA IX and CA XII promote the accumulation of exceeding protons and acidosis in the extracellular tumor environment. Sulfonamides are effective inhibitors of most families of CAs. In this study, using scaffold-hopping, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Krymov, Stepan K., Scherbakov, Alexander M., Dezhenkova, Lyubov G., Salnikova, Diana I., Solov’eva, Svetlana E., Sorokin, Danila V., Vullo, Daniela, De Luca, Viviana, Capasso, Clemente, Supuran, Claudiu T., Shchekotikhin, Andrey E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783868/
https://www.ncbi.nlm.nih.gov/pubmed/36558903
http://dx.doi.org/10.3390/ph15121453
_version_ 1784857675785306112
author Krymov, Stepan K.
Scherbakov, Alexander M.
Dezhenkova, Lyubov G.
Salnikova, Diana I.
Solov’eva, Svetlana E.
Sorokin, Danila V.
Vullo, Daniela
De Luca, Viviana
Capasso, Clemente
Supuran, Claudiu T.
Shchekotikhin, Andrey E.
author_facet Krymov, Stepan K.
Scherbakov, Alexander M.
Dezhenkova, Lyubov G.
Salnikova, Diana I.
Solov’eva, Svetlana E.
Sorokin, Danila V.
Vullo, Daniela
De Luca, Viviana
Capasso, Clemente
Supuran, Claudiu T.
Shchekotikhin, Andrey E.
author_sort Krymov, Stepan K.
collection PubMed
description The overexpression and activity of carbonic anhydrase (CA, EC 4.2.1.1) isoforms CA IX and CA XII promote the accumulation of exceeding protons and acidosis in the extracellular tumor environment. Sulfonamides are effective inhibitors of most families of CAs. In this study, using scaffold-hopping, indoline-5-sulfonamide analogs 4a–u of the CA IX-selective inhibitor 3 were designed and synthesized to evaluate their biological properties. 1-Acylated indoline-5-sulfonamides demonstrated inhibitory activity against tumor-associated CA IX and XII with K(I) values up to 132.8 nM and 41.3 nM. Compound 4f, as one of the most potent inhibitors of CA IX and XII, exhibits hypoxic selectivity, suppressing the growth of MCF7 cells at 12.9 µM, and causes partial inhibition of hypoxia-induced CA IX expression in A431 skin cancer cells. 4e and 4f reverse chemoresistance to doxorubicin of K562/4 with overexpression of P-gp.
format Online
Article
Text
id pubmed-9783868
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97838682022-12-24 Indoline-5-Sulfonamides: A Role of the Core in Inhibition of Cancer-Related Carbonic Anhydrases, Antiproliferative Activity and Circumventing of Multidrug Resistance Krymov, Stepan K. Scherbakov, Alexander M. Dezhenkova, Lyubov G. Salnikova, Diana I. Solov’eva, Svetlana E. Sorokin, Danila V. Vullo, Daniela De Luca, Viviana Capasso, Clemente Supuran, Claudiu T. Shchekotikhin, Andrey E. Pharmaceuticals (Basel) Article The overexpression and activity of carbonic anhydrase (CA, EC 4.2.1.1) isoforms CA IX and CA XII promote the accumulation of exceeding protons and acidosis in the extracellular tumor environment. Sulfonamides are effective inhibitors of most families of CAs. In this study, using scaffold-hopping, indoline-5-sulfonamide analogs 4a–u of the CA IX-selective inhibitor 3 were designed and synthesized to evaluate their biological properties. 1-Acylated indoline-5-sulfonamides demonstrated inhibitory activity against tumor-associated CA IX and XII with K(I) values up to 132.8 nM and 41.3 nM. Compound 4f, as one of the most potent inhibitors of CA IX and XII, exhibits hypoxic selectivity, suppressing the growth of MCF7 cells at 12.9 µM, and causes partial inhibition of hypoxia-induced CA IX expression in A431 skin cancer cells. 4e and 4f reverse chemoresistance to doxorubicin of K562/4 with overexpression of P-gp. MDPI 2022-11-23 /pmc/articles/PMC9783868/ /pubmed/36558903 http://dx.doi.org/10.3390/ph15121453 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Krymov, Stepan K.
Scherbakov, Alexander M.
Dezhenkova, Lyubov G.
Salnikova, Diana I.
Solov’eva, Svetlana E.
Sorokin, Danila V.
Vullo, Daniela
De Luca, Viviana
Capasso, Clemente
Supuran, Claudiu T.
Shchekotikhin, Andrey E.
Indoline-5-Sulfonamides: A Role of the Core in Inhibition of Cancer-Related Carbonic Anhydrases, Antiproliferative Activity and Circumventing of Multidrug Resistance
title Indoline-5-Sulfonamides: A Role of the Core in Inhibition of Cancer-Related Carbonic Anhydrases, Antiproliferative Activity and Circumventing of Multidrug Resistance
title_full Indoline-5-Sulfonamides: A Role of the Core in Inhibition of Cancer-Related Carbonic Anhydrases, Antiproliferative Activity and Circumventing of Multidrug Resistance
title_fullStr Indoline-5-Sulfonamides: A Role of the Core in Inhibition of Cancer-Related Carbonic Anhydrases, Antiproliferative Activity and Circumventing of Multidrug Resistance
title_full_unstemmed Indoline-5-Sulfonamides: A Role of the Core in Inhibition of Cancer-Related Carbonic Anhydrases, Antiproliferative Activity and Circumventing of Multidrug Resistance
title_short Indoline-5-Sulfonamides: A Role of the Core in Inhibition of Cancer-Related Carbonic Anhydrases, Antiproliferative Activity and Circumventing of Multidrug Resistance
title_sort indoline-5-sulfonamides: a role of the core in inhibition of cancer-related carbonic anhydrases, antiproliferative activity and circumventing of multidrug resistance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783868/
https://www.ncbi.nlm.nih.gov/pubmed/36558903
http://dx.doi.org/10.3390/ph15121453
work_keys_str_mv AT krymovstepank indoline5sulfonamidesaroleofthecoreininhibitionofcancerrelatedcarbonicanhydrasesantiproliferativeactivityandcircumventingofmultidrugresistance
AT scherbakovalexanderm indoline5sulfonamidesaroleofthecoreininhibitionofcancerrelatedcarbonicanhydrasesantiproliferativeactivityandcircumventingofmultidrugresistance
AT dezhenkovalyubovg indoline5sulfonamidesaroleofthecoreininhibitionofcancerrelatedcarbonicanhydrasesantiproliferativeactivityandcircumventingofmultidrugresistance
AT salnikovadianai indoline5sulfonamidesaroleofthecoreininhibitionofcancerrelatedcarbonicanhydrasesantiproliferativeactivityandcircumventingofmultidrugresistance
AT solovevasvetlanae indoline5sulfonamidesaroleofthecoreininhibitionofcancerrelatedcarbonicanhydrasesantiproliferativeactivityandcircumventingofmultidrugresistance
AT sorokindanilav indoline5sulfonamidesaroleofthecoreininhibitionofcancerrelatedcarbonicanhydrasesantiproliferativeactivityandcircumventingofmultidrugresistance
AT vullodaniela indoline5sulfonamidesaroleofthecoreininhibitionofcancerrelatedcarbonicanhydrasesantiproliferativeactivityandcircumventingofmultidrugresistance
AT delucaviviana indoline5sulfonamidesaroleofthecoreininhibitionofcancerrelatedcarbonicanhydrasesantiproliferativeactivityandcircumventingofmultidrugresistance
AT capassoclemente indoline5sulfonamidesaroleofthecoreininhibitionofcancerrelatedcarbonicanhydrasesantiproliferativeactivityandcircumventingofmultidrugresistance
AT supuranclaudiut indoline5sulfonamidesaroleofthecoreininhibitionofcancerrelatedcarbonicanhydrasesantiproliferativeactivityandcircumventingofmultidrugresistance
AT shchekotikhinandreye indoline5sulfonamidesaroleofthecoreininhibitionofcancerrelatedcarbonicanhydrasesantiproliferativeactivityandcircumventingofmultidrugresistance